IL2 and neoplasm: Importantly, despite its potent anti-tumor efficacy, the synNotch→ IL-2 circuit showed no evidence of systemic cytokine toxicity or exacerbation of CAR T cell toxicity, as assessed by mouse survival, body weight, spleen weight, and measurements of hepatotoxicity (Fig S10).